Inclusion of malignant fibrous histiocytoma in the tumour spectrum associated with hereditary non-polyposis colorectal cancer

✍ Scribed by Rolf Sijmons; Robert Hofstra; Harry Hollema; Rob Mensink; Annemieke van der Hout; Harald Hoekstra; Jan Kleibeuker; Willemina Molenaar; Juul Wijnen; Riccardo Fodde; Hans Vasen; Charles Buys

• Publisher: John Wiley and Sons
• Year: 2000
• Tongue: English
• Weight: 56 KB
• Volume: 29
• Category: Article
• ISSN: 1045-2257
• DOI: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1042>3.0.co;2-t

✦ Synopsis

Sarcomas, including the malignant fibrous histiocytomas (MFHs), are not known to be part of the tumour spectrum of hereditary non-polyposis colorectal cancer (HNPCC) as epidemiologically established. Therefore, occurrence of MFH in an HNPCC family may very well be coincidental. HNPCC is associated with germline mutations in DNA mismatch repair genes, including the MSH2 gene. We analysed an MFH diagnosed in a 45-year-old male HNPCC patient carrying a germline MSH2 mutation for HNPCC-associated molecular characteristics, to investigate a possible relationship between the tumour and that mutation. DNA analysis revealed microsatellite instability and loss of one MSH2 copy, and immunohistochemistry showed absence of nuclear MSH2 protein staining. To investigate whether this is a common finding in MFH, microsatellite instability and nuclear MSH2 protein staining was tested for in 5 and 6 sporadic MFHs, respectively. None showed microsatellite instability and all stained positively for MSH2. Together, these findings show that in rare cases, MFH may be part of the HNPCC tumour spectrum.